Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes

Diabetes Care

Volumn 27, Issue 8, 2004, Pages 2021-2026

  Sivenius, Katariina ^a   Pihlajamäki, Jussi ^a   Partanen, Juhani ^a   Niskanen, Leo ^a   Laakso, Markku ^a   Uusitupa, Matti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; DNA; GUANINE; THYMINE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FINLAND; FLUORESCENCE; FOLLOW UP; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE; NERVE CONDUCTION; NERVE FUNCTION; NEUROPHYSIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PERONEUS NERVE; POLYMERASE CHAIN REACTION; RADIAL NERVE; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SURAL NERVE;

ALDEHYDE REDUCTASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES;

EID: 3342925853     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.8.2021     Document Type: Article

References (25)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. U.K. Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
3. Kinoshita JH, Nishimura C: The involvement of aldose reductase in diabetic complications. Diabete Metab Rev 4:323-337, 1988
4. Graham A, Brown L, Hedge PJ, Gammack AJ, Markham AF: Structure of the human aldose reductase gene. J Biol Chem 266: 6872-6877, 1991
5. Wang K, Bohren KM, Gabbay KH: Characterization of the human aldose reductase gene promoter. J Biol Chem 268: 16052-16058, 1993
6. Ko BC, Lam KS, Wat NM, Chung SS: An (A-C)n dinucleotide repeat polymorphic marker at the 5′ end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 44:727-732, 1995
7. Heesom AE, Millward A, Demaine AG: Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase. gene. J Neurol Neurosurg Psychiatry 64:213-216, 1998
8. Ichikawa F, Yamada K, Ishiyama-Shigemoto S, Yuan X, Nonaka K: Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5′-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with type 2 diabetes mellitus. Diabet Med 16:744-748, 1999
9. Ng DP, Conn J, Chung SS, Larkins RG: Aldose reductase (AC)(n) microsatellite polymorphism and diabetic microvascular complications in Caucasian type 1 diabetes mellitus. Diabetes Res Clin Pract 52: 21-27, 2001
10. Shah VO, Scavini M, Nikolic J, Sun Y, Vai S, Griffith JK, Dorin RI, Stidley C, Yacoub M, Vander Jagt DL, Eaton RP, Zager PG: Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab 83:2886-2891, 1998
11. Kao YL, Donaghue K, Chan A, Knight J, Silink M: A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes 48:1338-1340, 1999
12. Demaine A, Cross D, Millward A: Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci 41:4064-4068, 2000
13. Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich SS, Warram JH, Krolewski AS: Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in type 1 diabetes mellitus. Diabet Med 17:111-118, 2000
14. Neamat-Allah M, Feeney SA, Savage DA, Maxwell AP, Hanson RL, Knowler WC, El Nahas AM, Plater ME, Shaw J, Boulton AJ, Duff GW, Cox A: Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in type 1 and type 2 diabetes mellitus. Diabet Med 18:906-914, 2001
15. Uusitupa M, Siitonen O, Aro A, Pyorälä K: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 28:22-27, 1985
16. Niskanen L, Karjalainen J, Siitonen O, Uusitupa M: Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis. J Intern Med 236:263-270, 1994
17. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
18. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M: Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333:89-94, 1995
19. Thompson EA, Deeb S, Walker D, Motulsky AG: The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet 42:113-124, 1988
20. Li Q, Xie P, HuangJ, Gu Y, Zeng W, Song H: Polymorphisms and functions of the aldose reductase gene 5′ regulatory region in Chinese patients with type 2 diabetes mellitus. Chin Med J 115:209-213, 2002
21. Harati Y: Frequently asked questions about diabetic peripheral neuropathies. Neurol Clin 10:783-807, 1992
22. Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF: Nerve glucose, fructose, sorbitol, myoinositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 319:542-548, 1988
23. Sundkvist G, Dahlin L-B, Nilsson H, Eriksson K-F, Lindgärde F, Rosen I, Lattimer SA, Sima AAF, Sullivan K, Greene DA: Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance. Diabet Med 17:259-268, 2000
24. Ludvigson MA, Sorenson RL: Immunohistochemical localization of aldose reductase I enzyme purification and antibody preparation-localization in peripheral nerve, artery, and testis. Diabetes 29: 438-449, 1980
25. Chistyakov DA, Savost'anov KV, Zotova EV, Nosikov VV: Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet 2:4 Epub, 2001